Search Results

There are 11114 results for: content related to: The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy

  1. You have free access to this content
    Evaluation of hypophosphataemia in tenofovir disoproxil fumarate (TDF)-exposed and TDF-unexposed HIV-infected out-patients receiving highly active antiretroviral therapy

    HIV Medicine

    Volume 7, Issue 7, October 2006, Pages: 451–456, K Buchacz, JT Brooks, T Tong, AC Moorman, RK Baker, SD Holmberg, A Greenberg and the HIV Outpatient Study (HOPS) Investigators

    Article first published online : 22 AUG 2006, DOI: 10.1111/j.1468-1293.2006.00407.x

  2. You have free access to this content
    Incidence of and risk factors for tenofovir-induced nephrotoxicity: a retrospective cohort study

    HIV Medicine

    Volume 6, Issue 4, July 2005, Pages: 284–290, T Antoniou, JM Raboud, S Chirhin, D Yoong, V Govan, K Gough, A Rachlis and MR Loutfy

    Article first published online : 1 JUL 2005, DOI: 10.1111/j.1468-1293.2005.00308.x

  3. Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B

    Alimentary Pharmacology & Therapeutics

    Volume 41, Issue 3, February 2015, Pages: 310–319, S. Koklu, M. T. Gulsen, Y. Tuna, H. Koklu, O. Yuksel, M. Demir, R. Guner, Z. Dogan, M. Kucukazman, O. K. Poyrazoglu, M. Biyik, N. A. Ozturk, T. Aydogan, S. Coban, O. Kocaman, F. Sapmaz, S. H. Gokturk, C. Karaca, A. Demirezer, A. Tanoglu, B. Yildirim, A. Altinbas, B. M. Atak, A. M. Cosar and E. Alkan

    Article first published online : 4 DEC 2014, DOI: 10.1111/apt.13036

  4. You have free access to this content
    Fibroblast growth factor 23 in hypophosphataemic HIV-positive adults on tenofovir

    HIV Medicine

    Volume 13, Issue 9, October 2012, Pages: 558–563, A Bech, P Van Bentum, K Nabbe, J Gisolf, C Richter and H De Boer

    Article first published online : 30 MAR 2012, DOI: 10.1111/j.1468-1293.2012.01015.x

  5. Acute kidney injury caused by tenofovir disoproxil fumarate and diclofenac co-administration

    HIV Medicine

    Volume 14, Issue 10, November 2013, Pages: 633–638, M Bickel, P Khaykin, C Stephan, K Schmidt, M Buettner, K Amann, T Lutz, P Gute, A Haberl, H Geiger, HR Brodt and O Jung

    Article first published online : 27 AUG 2013, DOI: 10.1111/hiv.12072

  6. You have free access to this content
    Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B

    Alimentary Pharmacology & Therapeutics

    Volume 35, Issue 11, June 2012, Pages: 1317–1325, N. Gara, X. Zhao, M. T. Collins, W. H. Chong, D. E. Kleiner, T. Jake Liang, M. G. Ghany and J. H. Hoofnagle

    Article first published online : 16 APR 2012, DOI: 10.1111/j.1365-2036.2012.05093.x

  7. You have free access to this content
    Assessment of the steady-state pharmacokinetic interaction between etravirine administered as two different formulations and tenofovir disoproxil fumarate in healthy volunteers

    HIV Medicine

    Volume 10, Issue 3, March 2009, Pages: 173–181, TN Kakuda, M Schöller-Gyüre, G De Smedt, G Beets, F Aharchi, MP Peeters, K Vandermeulen, BJ Woodfall and RMW Hoetelmans

    Article first published online : 8 JAN 2009, DOI: 10.1111/j.1468-1293.2008.00668.x

  8. Tenofovir for the Treatment of Hepatitis B Virus

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 29, Issue 10, October 2009, Pages: 1212–1227, Dr. Alice M. Jenh, Dr. Chloe L. Thio and Dr. Paul A. Pham

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.29.10.1212

  9. Tenofovir: A Nucleotide Analog for The Management of Human Immunodeficiency Virus Infection

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 23, Issue 1, January 2003, Pages: 29–43, Tony Antoniou, Laura Y. Park-Wyllie and Alice L. Tseng

    Article first published online : 16 JAN 2012, DOI: 10.1592/phco.23.1.29.31915

  10. The rate of recovery in renal function when patients with HIV infection discontinue treatment with tenofovir

    HIV Medicine

    Volume 15, Issue 8, September 2014, Pages: 505–510, J Young, Q Wang, CA Fux, E Bernasconi, H Furrer, P Vernazza, A Calmy, M Cavassini, R Weber, M Battegay, HC Bucher and and theSwiss HIV Cohort Study

    Article first published online : 18 MAR 2014, DOI: 10.1111/hiv.12149

  11. Switch from tenofovir to raltegravir increases low bone mineral density and decreases markers of bone turnover over 48 weeks

    HIV Medicine

    Volume 15, Issue 6, July 2014, Pages: 373–380, M Bloch, WWY Tong, J Hoy, D Baker, FJ Lee, R Richardson, A Carr and for the TROP (Switch from Tenofovir to Raltegravir for Low Bone Density) study team

    Article first published online : 26 JAN 2014, DOI: 10.1111/hiv.12123

  12. You have free access to this content
    British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013

    HIV Medicine

    Volume 14, Issue S4, November 2013, Pages: 1–71, Writing Group, Dr Ed Wilkins, Dr Mark Nelson, Dr Kosh Agarwal, Ms Dola Awoyemi, Dr Eleanor Barnes, Dr Sanjay Bhagani, Dr Gary Brook, Dr Ashley Brown, Ms Sheena Castelino, Dr Graham Cooke, Prof Martin Fisher, Prof Anna Maria Geretti, Mr Robert James, Dr Ranjababu Kulasegaram, Prof Clifford Leen, Prof David Mutimer, Dr Chloe Orkin, Dr Emma Page, Dr Adrian Palfreeman, Dr Padmasayee Papineni, Dr Alison Rodger and Dr CY William Tong

    Article first published online : 25 OCT 2013, DOI: 10.1111/hiv.12106

  13. A randomized clinical trial comparing metabolic parameters after 48 weeks of standard- and low-dose stavudine therapy and tenofovir disoproxil fumarate therapy in HIV-infected South African patients

    HIV Medicine

    Volume 15, Issue 1, January 2014, Pages: 3–12, CN Menezes, NJ Crowther, R Duarte, D Van Amsterdam, D Evans, C Dickens, T Dix-Peek, M Rassool, A Prinsloo, F Raal and I Sanne

    Article first published online : 27 AUG 2013, DOI: 10.1111/hiv.12074

  14. You have free access to this content
    Tenofovir-associated renal and bone toxicity

    HIV Medicine

    Volume 10, Issue 8, September 2009, Pages: 482–487, CLN Woodward, AM Hall, IG Williams, S Madge, A Copas, D Nair, SG Edwards, MA Johnson and JO Connolly

    Article first published online : 6 MAY 2009, DOI: 10.1111/j.1468-1293.2009.00716.x

  15. A meta-analysis comparing the efficacy of entecavir and tenofovir for the treatment of chronic hepatitis B infection

    The Journal of Clinical Pharmacology

    Volume 55, Issue 3, March 2015, Pages: 288–297, Shan-Ru Zuo, Xiao-Cong Zuo, Chun-Jiang Wang, Yu-Tao Ma, Hao-Ye Zhang, Zuo-Jun Li, Li-Ying Song, Zhen-Zhen Deng and Shi-Kun Liu

    Article first published online : 20 NOV 2014, DOI: 10.1002/jcph.409

  16. You have free access to this content
    Randomized, placebo-controlled trial of tenofovir disoproxil fumarate in adolescents with chronic hepatitis B

    Hepatology

    Volume 56, Issue 6, December 2012, Pages: 2018–2026, Karen F. Murray, Leszek Szenborn, Jacek Wysocki, Stephen Rossi, Amoreena C. Corsa, Phillip Dinh, John McHutchison, Phillip S. Pang, Luminita M. Luminos, Malgorzata Pawlowska and Jacek Mizerski

    Article first published online : 27 AUG 2012, DOI: 10.1002/hep.25818

  17. Steady-State Pharmacokinetics of Emtricitabine and Tenofovir Disoproxil Fumarate Administered Alone and in Combination in Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 47, Issue 6, June 2007, Pages: 751–759, M. Robert Blum, Gregory E. Chittick, John A. Begley and Jian Zong

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270007300951

  18. Tenofovir: Quo Vadis Anno 2012 (Where Is It Going in the Year 2012)?

    Medicinal Research Reviews

    Volume 32, Issue 4, July 2012, Pages: 765–785, Erik De Clercq

    Article first published online : 11 MAY 2012, DOI: 10.1002/med.21267

  19. Preformulation and development of a once-daily sustained-release tenofovir vaginal tablet tablet containing a single excipient

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 6, June 2013, Pages: 1859–1868, Christopher Mcconville, David R. Friend, Meredith R. Clark and Karl Malcolm

    Article first published online : 8 APR 2013, DOI: 10.1002/jps.23528

  20. Maximized Mucoadhesion and Skin Permeation of Anti-AIDS-Loaded Niosomal Gels

    Journal of Pharmaceutical Sciences

    Volume 103, Issue 3, March 2014, Pages: 952–964, Ahmed S. Zidan and Muhammad J. Habib

    Article first published online : 24 JAN 2014, DOI: 10.1002/jps.23867